Status:
RECRUITING
National Registry and Cohort Study of Pulmonary Vascular Disease
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Conditions:
Pulmonary Arterial Hypertension
Eligibility:
All Genders
Brief Summary
This is a observational、multicenter, prospective cohort study for patients with pulmonary hypertension (PH). The purposes of this study were to evaluate the etiology、clinical characteristics、treatment...
Eligibility Criteria
Inclusion
- Newly diagnosed or previously diagnosed patients with PH.
- Documentation of mean pulmonary arterial pressure (mPAP) \>20 mm Hg by right heart catheterization, performed at any time prior to study enrollment.
Exclusion
- Have not had documentation of hemodynamic criteria for PH by right heart catheterization at some time preceding study entry and following development of symptoms associated with PH.
- Do not meet the required hemodynamic criteria for entry into the study.
Key Trial Info
Start Date :
March 29 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05368467
Start Date
March 29 2022
End Date
December 30 2028
Last Update
June 26 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial Peoples Hospital
Guangzhou, Guangdong, China
2
Nanjing First Hospital
Nanjing, Jiangsu, China, 210006
3
General Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China
4
Beijing Anzhen Hospital of Capital Medical University
Beijing, China